The Nodify CDT test measures levels of seven autoantibodies associated with lung cancer that can be detected in blood samples of patients with indeterminate lung nodules. Prior studies have ...
Biodesix announces positive study data for its Nodify CDT blood-based lung nodule test published in CHEST Pulmonary Journal.
MONDAY, Dec. 16, 2024 (HealthDay News) -- Folks with difficulty breathing can learn if they have COPD from a new AI-guided ...
Biodesix (BDSX) announced a new post-market clinical validation study was published in CHEST Pulmonary Journal that reaffirms the previously ...
“Our study shows that COPD diagnosis and staging is feasible with ... The main method of diagnosing COPD has been a spirometry test, which measures lung function through the quantity of air ...
A noninvasive approach could help clinicians prescribe medications more precisely for patients according to endotype.
COPD diagnosis has required two CT scans MONDAY, Dec. 16, 2024 (HealthDay News) -- Folks with difficulty breathing can learn if they have COPD from a new AI-guided lung test, a new study suggests.
The tool, developed by researchers at Pitt, could allow doctors to diagnose subtypes of the disease without putting patients ...